Compound | N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide | ||||
---|---|---|---|---|---|
CAS No. | 135463-81-9 | Catalog No. | 135463-81-9 | Brand | |
Purity | 99% | Packing | 1kg | Grade | |
Lead Time | Origin | Loading Port |
Boiling Point | 634.1ºC at 760 mmHg |
---|---|
Flash Point | 337.3ºC |
Refractive Index | 1.64 |
Density | 1.291g/cm3 |
Vapor Pressure | 5.54E-16mmHg at 25°C |
Product Name:Coluracetam
Synonyms:COLURACETAM;N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide;1-Pyrrolidineacetamide,2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-4-yl)-;Coluracetam, MKC-231;1-[N-(2,3-DiMethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)carbaMoylMethyl]pyrrolidin-2-one;BCI-540;Coluracetam, >=99%;2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethyl-furo[2,3-b]quinolin-4-yl)-1-pyrrolidineacetamide
CAS:135463-81-9
MF:C19H23N3O3
MW:341.4
EINECS:1308068-626-2
Uses
Copiracetam can be used as a nootropic drug to treat memory and intellectual impairments caused by senile dementia, mild to moderate vascular dementia, trauma and other diseases, and to promote children's intellectual development; it also has antidepressant effects.
Pharmacology
Copiracetam has the ability to improve cognition by participating in the HACU process, increasing the rate-limiting step of synaptic intake of choline to synthesize the neurotransmitter acetylcholine, and increasing the activity of cholinergic neurons.
tert-butyl 1-(2-methoxy-2-oxoethyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate
CAS No : 256407-56-4
N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
CAS No : 135463-81-9
CAS No : 916591-01-0
N-[(6-Chloro[1,3]dioxolo[4,5-g]quinolin-7-yl)methyl]-N-(2-methoxy ethyl)cyclopropanecarboxamide
CAS No : 606104-56-7
CAS No : 134296-40-5